Literature DB >> 19224780

Noninfectious serious hazards of transfusion.

Jeanne E Hendrickson1, Christopher D Hillyer.   

Abstract

As infectious complications from blood transfusion have decreased because of improved donor questionnaires and sophisticated infectious disease blood screening, noninfectious serious hazards of transfusion (NISHOTs) have emerged as the most common complications of transfusion. The category of NISHOTs is very broad, including everything from well-described and categorized transfusion reactions (hemolytic, febrile, septic, and allergic/urticarial/anaphylactic) to lesser known complications. These include mistransfusion, transfusion-related acute lung injury, transfusion-associated circulatory overload, posttransfusion purpura, transfusion-associated graft versus host disease, microchimerism, transfusion-related immunomodulation, alloimmunization, metabolic derangements, coagulopathic complications of massive transfusion, complications from red cell storage lesions, complications from over or undertransfusion, and iron overload. In recent years, NISHOTs have attracted more attention than ever before, both in the lay press and in the scientific community. As the list of potential complications from blood transfusion grows, investigators have focused on the morbidity and mortality of liberal versus restrictive red blood cell transfusion, as well as the potential dangers of transfusing "older" versus "younger" blood. In this article, we review NISHOTs, focusing on the most recent concerns and literature.

Entities:  

Mesh:

Year:  2009        PMID: 19224780     DOI: 10.1213/ane.0b013e3181930a6e

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  103 in total

1.  Red blood cell storage and transfusion-related immunomodulation.

Authors:  Rosemary L Sparrow
Journal:  Blood Transfus       Date:  2010-06       Impact factor: 3.443

2.  Transfusion complications in thalassemia patients: a report from the Centers for Disease Control and Prevention (CME).

Authors:  Elliott Vichinsky; Lynne Neumayr; Sean Trimble; Patricia J Giardina; Alan R Cohen; Thomas Coates; Jeanne Boudreaux; Ellis J Neufeld; Kristy Kenney; Althea Grant; Alexis A Thompson
Journal:  Transfusion       Date:  2013-07-25       Impact factor: 3.157

3.  Patterns of use of hemostatic agents in patients undergoing major surgery.

Authors:  Jason D Wright; Cande V Ananth; Sharyn N Lewin; William M Burke; Zainab Siddiq; Alfred I Neugut; Thomas J Herzog; Dawn L Hershman
Journal:  J Surg Res       Date:  2013-08-13       Impact factor: 2.192

4.  Safety and effects of two red blood cell transfusion strategies in pediatric cardiac surgery patients: a randomized controlled trial.

Authors:  D H de Gast-Bakker; R B P de Wilde; M G Hazekamp; V Sojak; J J Zwaginga; R Wolterbeek; E de Jonge; B J Gesink-van der Veer
Journal:  Intensive Care Med       Date:  2013-08-31       Impact factor: 17.440

5.  Properties of stored red blood cells: understanding immune and vascular reactivity.

Authors:  Philip C Spinella; Rosemary L Sparrow; John R Hess; Philip J Norris
Journal:  Transfusion       Date:  2011-04       Impact factor: 3.157

Review 6.  Mechanisms of Hemolysis During Sepsis.

Authors:  Katharina Effenberger-Neidnicht; Matthias Hartmann
Journal:  Inflammation       Date:  2018-10       Impact factor: 4.092

7.  Risk associated with perioperative red blood cell transfusion in cranial surgery.

Authors:  Jonathan A Cohen; Nima Alan; Andreea Seicean; Robert J Weil
Journal:  Neurosurg Rev       Date:  2017-02-03       Impact factor: 3.042

8.  Antibodies to major histocompatibility complex class II antigens directly prime neutrophils and cause acute lung injury in a two-event in vivo rat model.

Authors:  Marguerite R Kelher; Anirban Banerjee; Fabia Gamboni; Cameron Anderson; Christopher C Silliman
Journal:  Transfusion       Date:  2016-09-25       Impact factor: 3.157

Review 9.  Transfusion-induced bone marrow transplant rejection due to minor histocompatibility antigens.

Authors:  Seema R Patel; James C Zimring
Journal:  Transfus Med Rev       Date:  2013-10-03

10.  Clinically significant anti-KEL RBC alloantibodies are transferred by breast milk in a murine model.

Authors:  M Santhanakrishnan; C A Tormey; P Natarajan; J Liu; J E Hendrickson
Journal:  Vox Sang       Date:  2016-03-07       Impact factor: 2.144

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.